Escalon Medical Corp. (ESMC) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
40/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseESMC / S&P 11.11% / 15.20% |
LoseESMC / S&P ESMC unavailable / 15.00% |
LoseESMC / S&P ESMC unavailable / 50.40% |
| 2026-Q12/3 |
WinESMC / S&P 5.88% / -4.33% |
LoseESMC / S&P -11.60% / 11.30% |
WinESMC / S&P 120.00% / 27.70% |
| 2025-Q40/3 |
LoseESMC / S&P 0.00% / 2.65% |
LoseESMC / S&P 1.17% / 9.00% |
LoseESMC / S&P -400.00% / 13.40% |
| 2025-Q30/3 |
LoseESMC / S&P -46.88% / 8.12% |
LoseESMC / S&P 1.03% / 4.61% |
LoseESMC / S&P 0.00% / 13.45% |
| 2025-Q21/3 |
WinESMC / S&P 100.00% / 10.94% |
LoseESMC / S&P 0.54% / 4.83% |
LoseESMC / S&P -100.00% / 10.63% |
| 2025-Q12/3 |
WinESMC / S&P 23.08% / -4.27% |
WinESMC / S&P 11.18% / 4.98% |
LoseESMC / S&P -350.00% / 10.57% |
| 2024-Q40/3 |
LoseESMC / S&P -13.33% / 2.41% |
LoseESMC / S&P -1.74% / 5.25% |
LoseESMC / S&P -75.00% / 6.15% |
| 2024-Q31/3 |
WinESMC / S&P 7.14% / 5.89% |
LoseESMC / S&P -5.61% / 5.89% |
LoseESMC / S&P -140.00% / 6.11% |
| 2024-Q21/3 |
LoseESMC / S&P -44.00% / 4.28% |
LoseESMC / S&P -1.63% / 5.38% |
WinESMC / S&P 288230376151711616.00% / 5.12% |
| 2024-Q10/3 |
LoseESMC / S&P -3.85% / 10.56% |
LoseESMC / S&P -2.60% / 5.71% |
LoseESMC / S&P ESMC unavailable / 5.59% |
| 2023-Q41/3 |
LoseESMC / S&P -18.75% / 11.69% |
WinESMC / S&P 13.23% / 6.81% |
LoseESMC / S&P -150.00% / 7.78% |
| 2023-Q32/3 |
WinESMC / S&P 28.00% / -3.27% |
WinESMC / S&P 17.75% / 7.52% |
LoseESMC / S&P -155.56% / -5.03% |
| 2023-Q22/3 |
WinESMC / S&P 257.14% / 8.74% |
WinESMC / S&P 13.80% / 9.50% |
LoseESMC / S&P -100.00% / -8.57% |
| 2023-Q12/3 |
WinESMC / S&P 16.67% / 7.50% |
WinESMC / S&P 12.51% / 10.77% |
LoseESMC / S&P ESMC unavailable / -15.69% |
| 2022-Q40/3 |
LoseESMC / S&P -33.33% / 7.56% |
LoseESMC / S&P 3.82% / 11.88% |
LoseESMC / S&P -500.00% / -17.99% |
| 2022-Q30/3 |
LoseESMC / S&P -30.77% / -4.88% |
LoseESMC / S&P -0.93% / 13.47% |
LoseESMC / S&P -325.00% / -1.41% |
| 2022-Q22/3 |
WinESMC / S&P -13.33% / -16.10% |
LoseESMC / S&P 2.21% / 13.71% |
WinESMC / S&P 100.00% / 11.04% |
| 2022-Q11/3 |
WinESMC / S&P 36.36% / -4.60% |
LoseESMC / S&P 10.10% / 15.97% |
LoseESMC / S&P -100.00% / 42.23% |
| 2021-Q40/3 |
LoseESMC / S&P -56.00% / 11.03% |
LoseESMC / S&P 8.79% / 15.00% |
LoseESMC / S&P -120.00% / 96.40% |
| 2021-Q32/3 |
WinESMC / S&P 19.05% / 0.58% |
WinESMC / S&P 12.67% / 10.77% |
LoseESMC / S&P -120.00% / 69.42% |
| 2021-Q21/3 |
LoseESMC / S&P -40.00% / 8.55% |
WinESMC / S&P 11.40% / 6.58% |
LoseESMC / S&P -91.67% / 51.81% |
| 2021-Q13/3 |
WinESMC / S&P 169.23% / 6.17% |
WinESMC / S&P -0.15% / -1.06% |
WinESMC / S&P 66.67% / 7.39% |
| 2020-Q43/3 |
WinESMC / S&P 30.00% / 12.15% |
WinESMC / S&P -2.94% / -3.72% |
WinESMC / S&P 150.00% / -33.42% |
| 2020-Q31/3 |
LoseESMC / S&P -23.08% / 8.93% |
WinESMC / S&P -1.35% / -2.04% |
LoseESMC / S&P -1100.00% / -27.10% |
| 2020-Q21/3 |
LoseESMC / S&P -31.58% / 20.54% |
LoseESMC / S&P -2.35% / -0.46% |
WinESMC / S&P 200.00% / -27.11% |
| 2020-Q12/3 |
WinESMC / S&P 26.67% / -19.60% |
LoseESMC / S&P -4.30% / 3.47% |
WinESMC / S&P 50.00% / -14.75% |
| 2019-Q41/3 |
WinESMC / S&P 15.38% / 9.07% |
LoseESMC / S&P -0.89% / 5.36% |
LoseESMC / S&P -33.33% / 2.99% |
| 2019-Q31/3 |
WinESMC / S&P 8.33% / 1.70% |
LoseESMC / S&P -12.46% / 5.02% |
LoseESMC / S&P -66.67% / 0.21% |
| 2019-Q21/3 |
WinESMC / S&P 33.33% / 4.30% |
LoseESMC / S&P -15.57% / 6.64% |
LoseESMC / S&P -166.67% / 8.65% |
| 2019-Q10/3 |
LoseESMC / S&P -25.00% / 13.65% |
LoseESMC / S&P -12.50% / 8.12% |
LoseESMC / S&P -200.00% / 14.29% |
| 2018-Q40/3 |
LoseESMC / S&P -63.64% / -13.52% |
LoseESMC / S&P -14.35% / 9.05% |
LoseESMC / S&P -220.00% / 18.23% |
| 2018-Q31/3 |
WinESMC / S&P 43.48% / 7.71% |
LoseESMC / S&P -4.35% / 10.21% |
LoseESMC / S&P -220.00% / 19.06% |
| 2018-Q20/3 |
LoseESMC / S&P -23.33% / 3.43% |
LoseESMC / S&P 1.49% / 9.03% |
LoseESMC / S&P -166.67% / 14.46% |
| 2018-Q11/3 |
WinESMC / S&P 42.86% / -0.76% |
LoseESMC / S&P 4.47% / 7.68% |
LoseESMC / S&P -128.57% / 12.46% |
| 2017-Q41/3 |
WinESMC / S&P 40.00% / 6.64% |
LoseESMC / S&P 4.00% / 7.03% |
LoseESMC / S&P -135.71% / 13.82% |
| 2017-Q30/3 |
LoseESMC / S&P -28.57% / 4.48% |
LoseESMC / S&P 3.64% / 5.68% |
LoseESMC / S&P -70.59% / 17.57% |
| 2017-Q21/3 |
WinESMC / S&P 110.00% / 3.09% |
LoseESMC / S&P -2.95% / 4.83% |
LoseESMC / S&P -43.75% / 17.74% |
| 2017-Q11/3 |
LoseESMC / S&P -9.09% / 6.07% |
LoseESMC / S&P -9.77% / 3.67% |
WinESMC / S&P 40.00% / 13.32% |
| 2016-Q41/3 |
LoseESMC / S&P -83.58% / 3.82% |
LoseESMC / S&P -10.14% / 2.09% |
WinESMC / S&P 75.00% / 7.05% |
| 2016-Q31/3 |
LoseESMC / S&P -14.10% / 3.85% |
LoseESMC / S&P -16.26% / 0.20% |
WinESMC / S&P 240.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ESMC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -39.29% | 20.78% |
| Annualized return | -39.29% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ESMC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 13.33% | 83.14% |
| Annualized return | 2.53% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ESMC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -76.39% | 319.30% |
| Annualized return | -13.44% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.